Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 74 of 74 entries
Sorted by: Best Match Show Resources per page
Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean.

Biosensors

Kutateladze T, Bitskinashvili K, Sapojnikova N, Kartvelishvili T, Asatiani N, Vishnepolsky B, Datukishvili N.
PMID: 34940238
Biosensors (Basel). 2021 Nov 26;11(12). doi: 10.3390/bios11120481.

Allergenicity assessment of transgenic plants and foods is important for food safety, labeling regulations, and health protection. The aim of this study was to develop an effective multi-allergen diagnostic approach for transgenic soybean assessment. For this purpose, multiplex polymerase...

Cite
Kutateladze T, Bitskinashvili K, Sapojnikova N, et al. Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean. Biosensors (Basel). 2021;11(12)doi: 10.3390/bios11120481.
Kutateladze, T., Bitskinashvili, K., Sapojnikova, N., Kartvelishvili, T., Asatiani, N., Vishnepolsky, B., & Datukishvili, N. (2021). Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean. Biosensors, 11(12), . https://doi.org/10.3390/bios11120481
Kutateladze, Tamara, et al. "Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean." Biosensors vol. 11,12 (2021). doi: https://doi.org/10.3390/bios11120481
Kutateladze T, Bitskinashvili K, Sapojnikova N, Kartvelishvili T, Asatiani N, Vishnepolsky B, Datukishvili N. Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean. Biosensors (Basel). 2021 Nov 26;11(12). doi: 10.3390/bios11120481. PMID: 34940238.
Copy Download .nbib Format: NLM
A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Cell discovery

Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL.
PMID: 32793389
Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020.

No abstract available.

Cite
Burgoyne AM, Vann KR, Joshi S, et al. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020;6(1):49doi: 10.1038/s41421-020-0181-z.
Burgoyne, A. M., Vann, K. R., Joshi, S., Morales, G. A., Vega, F. M., Singh, A., Pal, D., Merati, A. B., Kutateladze, T. G., & Durden, D. L. (2020). A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell discovery, 6(1), 49. https://doi.org/10.1038/s41421-020-0181-z
Burgoyne, Adam M, et al. "A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity." Cell discovery vol. 6,1 (2020): 49. doi: https://doi.org/10.1038/s41421-020-0181-z
Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020. PMID: 32793389; PMCID: PMC7385619.
Copy Download .nbib Format: NLM
Showing 73 to 74 of 74 entries